162 related articles for article (PubMed ID: 15300251)
1. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Huusko P; Ponciano-Jackson D; Wolf M; Kiefer JA; Azorsa DO; Tuzmen S; Weaver D; Robbins C; Moses T; Allinen M; Hautaniemi S; Chen Y; Elkahloun A; Basik M; Bova GS; Bubendorf L; Lugli A; Sauter G; Schleutker J; Ozcelik H; Elowe S; Pawson T; Trent JM; Carpten JD; Kallioniemi OP; Mousses S
Nat Genet; 2004 Sep; 36(9):979-83. PubMed ID: 15300251
[TBL] [Abstract][Full Text] [Related]
2. NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer.
Wolf M; Edgren H; Muggerud A; Kilpinen S; Huusko P; Sørlie T; Mousses S; Kallioniemi O
Cell Oncol; 2005; 27(3):169-73. PubMed ID: 16037637
[TBL] [Abstract][Full Text] [Related]
3. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
[TBL] [Abstract][Full Text] [Related]
4. Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.
Ivanov I; Lo KC; Hawthorn L; Cowell JK; Ionov Y
Oncogene; 2007 May; 26(20):2873-84. PubMed ID: 17086209
[TBL] [Abstract][Full Text] [Related]
5. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
[TBL] [Abstract][Full Text] [Related]
6. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
Xu J; Gao M; Fan S; Meng Q; Goldberg ID; Abounader R; Ressom H; Laterra JJ; Rosen EM
Oncogene; 2007 May; 26(20):2925-38. PubMed ID: 17099727
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability.
Ionov Y; Nowak N; Perucho M; Markowitz S; Cowell JK
Oncogene; 2004 Jan; 23(3):639-45. PubMed ID: 14737099
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers.
Song JH; Kim CJ; Cho YG; Kwak HJ; Nam SW; Yoo NJ; Lee JY; Park WS
APMIS; 2007 Feb; 115(2):164-8. PubMed ID: 17295683
[TBL] [Abstract][Full Text] [Related]
10. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of WFDC1/ps20 gene in prostate cancer.
Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C
Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342
[TBL] [Abstract][Full Text] [Related]
12. Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.
Bloethner S; Mould A; Stark M; Hayward NK
Genes Chromosomes Cancer; 2008 Dec; 47(12):1076-85. PubMed ID: 18677770
[TBL] [Abstract][Full Text] [Related]
13. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
[TBL] [Abstract][Full Text] [Related]
14. From mRNA to tumor suppressor.
Mercola D; Welsh J
Nat Genet; 2004 Sep; 36(9):937-8. PubMed ID: 15340430
[TBL] [Abstract][Full Text] [Related]
15. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
[TBL] [Abstract][Full Text] [Related]
16. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer.
Watson JE; Doggett NA; Albertson DG; Andaya A; Chinnaiyan A; van Dekken H; Ginzinger D; Haqq C; James K; Kamkar S; Kowbel D; Pinkel D; Schmitt L; Simko JP; Volik S; Weinberg VK; Paris PL; Collins C
Oncogene; 2004 Apr; 23(19):3487-94. PubMed ID: 15007382
[TBL] [Abstract][Full Text] [Related]
17. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
[TBL] [Abstract][Full Text] [Related]
18. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
19. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
[TBL] [Abstract][Full Text] [Related]
20. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
